News
Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for ...
Meril Life Sciences announced one-year results from its pivotal LANDMARK trial, presented during the prestigious ...
The Food and Drug Administration (FDA) will require more evidence for what top officials describe as the uniquely American ...
First Study to Confirm Safety of Stabilized Hyaluronic Acid (sHA) Rectal Spacer in Cases with Rectal Wall Infiltration (RWI).4 ...
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...
"My impression is that Bobby's comments were misinterpreted. He supports academic freedom also," NIH Director Bhattacharya says in response to portrayal that Secretary Kennedy undermined him.
Equity Insider News Commentary – With early onset cancer rates on the rise and funding being cut to NIH, the future for cancer patients is increasingly being shaped not by public institutions, but by ...
This designation is meaningful as it signifies our continued commitment to making biosimilars more accessible. Both biosimilars and interchangeable biosimilars are highly similar and have no ...
1d
News-Medical.Net on MSNAvelumab and cetuximab combination shows promise in phase II skin cancer trialA phase II clinical trial led by the Alliance for Clinical Trials in Oncology has met its primary endpoint, demonstrating ...
2d
News-Medical.Net on MSNMass General Brigham researchers share cancer research discoveries at ASCO 2025Researchers from Mass General Brigham will present research discoveries and outcomes from clinical trials in cancer at the ...
The SWOG S2302 Pragmatica-Lung trial, which broke new ground with its streamlined pragmatic design, unusually broad ...
The U.S. Food and Drug Administration (FDA) on Tuesday detailed its new regulatory framework for COVID-19 vaccines, setting a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results